NATCO PHARMA LTD. (NATCOPHARM) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.[1]NATCO has established its presence in all three business segments viz. finished dosage…
Natco Pharma Ltd.
NATCOPHARM
Market Cap₹16,458Cr.
Current Price₹919
High / Low₹1,227/789
Stock P/E12.8
Book Value₹478
Dividend Yield0.64%
ROCE16.6%
ROE16.1%
Face Value₹2.00
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.[1]NATCO has established its presence in all three business segments viz. finished dosage formulations (“FDF”), active pharmaceutical ingredients (“APIs”), Contract Manufacturing Business.[2]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 15:04:59